<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rmt</journal-id><journal-title-group><journal-title xml:lang="ru">Общая реаниматология</journal-title><trans-title-group xml:lang="en"><trans-title>General Reanimatology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-9779</issn><issn pub-type="epub">2411-7110</issn><publisher><publisher-name>FSBI "SRIGR" RAMS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15360/1813-9779-2008-2-38</article-id><article-id custom-type="elpub" pub-id-type="custom">rmt-788</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>УЛУЧШЕНИЕ РАБОТЫ ОРИТ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OPTIMIZATION OF ICU</subject></subj-group></article-categories><title-group><article-title>Динамика цитокинов при проведении постоянной высокообъемной гемодиафильтрации (ПВГДФ)</article-title><trans-title-group xml:lang="en"><trans-title>Time Course of Changes during Continuous High-Volume Hemodiafiltration</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пурло</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Purlo</surname><given-names>N. V.</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Левина</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Levina</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мамукова</surname><given-names>Ю. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Mamukova</surname><given-names>Yu. I.</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бирюкова</surname><given-names>Л. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Biryukova</surname><given-names>L. S.</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib></contrib-group><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>20</day><month>04</month><year>2008</year></pub-date><volume>4</volume><issue>2</issue><issue-title>Том IV № 2 2008 г.</issue-title><fpage>38</fpage><lpage>38</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Пурло Н.В., Левина А.А., Мамукова Ю.И., Бирюкова Л.С., 2008</copyright-statement><copyright-year>2008</copyright-year><copyright-holder xml:lang="ru">Пурло Н.В., Левина А.А., Мамукова Ю.И., Бирюкова Л.С.</copyright-holder><copyright-holder xml:lang="en">Purlo N.V., Levina A.A., Mamukova Y.I., Biryukova L.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.reanimatology.com/rmt/article/view/788">https://www.reanimatology.com/rmt/article/view/788</self-uri><abstract><p>Цель исследования . Оценка динамики уровня цитокинов, ферритина и эндотелина в периферической крови и фильтрате у пациентов с полиорганной дисфункцией на фоне проведения ПВГДФ. Материал и методы. Обследовано 28 больных в возрасте от 32 до 69 лет с тяжестью состояния по шкале APACHЕ II от 31 до 36 баллов. Результаты. Выявлено, что до проведения ПВГДФ у больных отмечался повышенный уровень провоспалительных цитокинов в плазме крови. Во время ПВГДФ элиминировалось значительное количество цитокинов, причем уровень некоторых цитокинов в фильтрате был выше, чем в плазме крови, вероятно, в результате диссоциации медиаторов воспалительной реакции при прохождении через экстракорпоральный контур. Заключение. Отмечено, что уровни TNF-a, IL-2, IL-6 и IL-10 у выживших больных были значительно выше, а IL-13 и ферритина ниже, чем у умерших. К концу лечения отмечена тенденция к нормализации цитокинов у выживших больных. После проведения дальнейших исследований будут определены возможности использования уровня некоторых цитокинов в качестве прогностических факторов оценки тяжести состояния больного. Ключевые слова: цитокины, ПВГДФ, полиорганная дисфункция.</p></abstract><trans-abstract xml:lang="en"><p>Objective: to evaluate changes in the levels of cytokines, ferritin, and endothelin in the peripheral blood and filtrates of patients with multiple organ dysfunctions during continuous high-volume hemodiafiltration (CHVHDF). Subjects and methods: Twenty-eight patients aged 32 to 69 years with the severity of disease of 31 to 36 APACHE II scores were examined. Results. Prior to CHVHDF, the patients were found to have elevated plasma proinflammatory cytokines. During CHVHDF, the bulk of cytokines were eliminated, the levels of some cytokines were higher in the filtrate than in the plasma, presumably, due to the dissociation of inflammatory mediators passing through the extracorporeal circuit. Conclusion. In survivors, the levels of TNF-a, IL-2, IL-6, and IL-10 were much higher, but those of IL-13 and ferritin were lower than those in deceased patients. By the end of treatment, there was a trend for cytokines to become normal in the survivors. The possibilities of using the level of some cytokines as predictors for the evaluation of patients’ condition will be determined after further studies. Key words: cytokines, continuous high-volume hemodiafiltration, multiple organ dysfunctions.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Мороз В. В., Лукач В. Н., Шифман Е. М. и соавт.</mixed-citation><mixed-citation xml:lang="en">Мороз В. В., Лукач В. Н., Шифман Е. М. и соавт.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ступин В. А., Румянцева С. А.Синдром полиорганной недостаточности в клинике неотложной хирургии. В кн.: Критические состояния в хирургии. М.; 2005.152—174.</mixed-citation><mixed-citation xml:lang="en">Ступин В. А., Румянцева С. А.Синдром полиорганной недостаточности в клинике неотложной хирургии. В кн.: Критические состояния в хирургии. М.; 2005.152—174.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Цыбулькин Э. К.Сепсис в свете современных иммунологических воззрений. СПб.; 2002. 67.</mixed-citation><mixed-citation xml:lang="en">Цыбулькин Э. К.Сепсис в свете современных иммунологических воззрений. СПб.; 2002. 67.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Simmons E., Himmelfarb J, SezerM. et al.Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney International 2004; 65: 1357—1365.</mixed-citation><mixed-citation xml:lang="en">Simmons E., Himmelfarb J, SezerM. et al.Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney International 2004; 65: 1357—1365.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Stuber F.Another definite candidate gene for genetic predisposition of sepsis: Interleukin-10. Crit. Care Med. 2003; 31: 314—31</mixed-citation><mixed-citation xml:lang="en">Stuber F.Another definite candidate gene for genetic predisposition of sepsis: Interleukin-10. Crit. Care Med. 2003; 31: 314—31</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ronco C., Brendolan A., Dan M. et al.Adsorption in sepsis. Kidney International 2000; 58: 148—155.</mixed-citation><mixed-citation xml:lang="en">Ronco C., Brendolan A., Dan M. et al.Adsorption in sepsis. Kidney International 2000; 58: 148—155.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Tetta C., Bellomo R., D&amp;#8217;Intini V. et al.Do circulating cytokines really matter in sepsis? Kidney Int. Suppl. 2003; 84: 69—71.</mixed-citation><mixed-citation xml:lang="en">Tetta C., Bellomo R., D&amp;#8217;Intini V. et al.Do circulating cytokines really matter in sepsis? Kidney Int. Suppl. 2003; 84: 69—71.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Галстян Г. М.Септический шок и острая дыхательная недостаточность в гематологической клинике: автореф. дис&amp;#8230;д-ра мед. наук. М.; 2003.</mixed-citation><mixed-citation xml:lang="en">Галстян Г. М.Септический шок и острая дыхательная недостаточность в гематологической клинике: автореф. дис&amp;#8230;д-ра мед. наук. М.; 2003.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
